Trial Outcomes & Findings for Endoscopic Therapy of Malignant Bile Duct Strictures (NCT NCT01543607)
NCT ID: NCT01543607
Last Updated: 2017-04-24
Results Overview
Determination of safety will be measured by the presence of a bile leak( bile leak will be defined by contrast cholangiography)
TERMINATED
NA
1 participants
2 years
2017-04-24
Participant Flow
Participant milestones
| Measure |
Treatment
Radiofrequency ablation catheter
Radiofrequency ablation catheter (Habib EndoHBP): Catheter placement into bile duct
|
|---|---|
|
Overall Study
STARTED
|
1
|
|
Overall Study
COMPLETED
|
1
|
|
Overall Study
NOT COMPLETED
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Endoscopic Therapy of Malignant Bile Duct Strictures
Baseline characteristics by cohort
| Measure |
Treatment
n=1 Participants
Radiofrequency ablation catheter
Radiofrequency ablation catheter (Habib EndoHBP): Catheter placement into bile duct
|
|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
0 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Female
|
1 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
1 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 2 yearsDetermination of safety will be measured by the presence of a bile leak( bile leak will be defined by contrast cholangiography)
Outcome measures
| Measure |
Treatment
n=1 Participants
Radiofrequency ablation catheter
Radiofrequency ablation catheter (Habib EndoHBP): Catheter placement into bile duct
|
|---|---|
|
Safety: Number of Bile Leak After RFA Procedure
|
1 bile leak
|
SECONDARY outcome
Timeframe: 2 yearsDetermine the feasibility of radiofrequency ablation catheter placement across malignant strictures with using a subjective scale, 0 is being impossible to place the catheter and 10 is being very easy to place the catheter.
Outcome measures
| Measure |
Treatment
n=1 Participants
Radiofrequency ablation catheter
Radiofrequency ablation catheter (Habib EndoHBP): Catheter placement into bile duct
|
|---|---|
|
Feasibility: Ease of the Radiofrequency Ablation Catheter Placement
|
10 units on a scale
|
SECONDARY outcome
Timeframe: 2 yearsEffectiveness will be determined by change in stricture diameter (increase or decrease) after RFA procedure. This will be measure as percentage change in improvement of the stricture.
Outcome measures
| Measure |
Treatment
n=1 Participants
Radiofrequency ablation catheter
Radiofrequency ablation catheter (Habib EndoHBP): Catheter placement into bile duct
|
|---|---|
|
Effectiveness: Change From Baseline in Bile Duct Diameter.
|
50 percentage of improvement:
|
Adverse Events
Treatment
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place